Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.6150
+0.0250 (4.24%)
Feb 6, 2026, 4:00 PM EST - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.81 million as of February 6, 2026. Its market cap has decreased by -36.11% in one year.
Market Cap
12.81M
Enterprise Value
7.23M
1-Year Change
-36.11%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.81M, a decrease of -61.65%. That is a compound annual growth rate of -49.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 12.81M | -13.38% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 13.03M |
| BioLineRx | 12.58M |
| Cadrenal Therapeutics | 12.53M |
| CytoMed Therapeutics | 12.46M |
| BioAtla | 12.17M |
| Moleculin Biotech | 12.04M |
| NewcelX | 12.03M |
| Cellectar Biosciences | 11.96M |